Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Wegovy Pediatric Safety: What Parents Need to Know About Semaglutide for Children Under 12 Wegovy Pediatric (Under 12) Safety: Current Evidence and Clinical Guidance At a glance FDA-approved age range / Wegovy is approved for patients aged 12 years and older with obesity (BMI at or above the 95th percentile) Under-12 approval status / No FDA approval exists for semaglutide 2.4 mg in children below age 12 Key adolescent trial / STEP TEENS (N=201) demonstrated 16.1% mean BMI reduction at 68 weeks in adolescents aged 12 to 17 Pediatric trial gap / No completed RCT has enrolled children aged 6 to 11 for semaglutide 2.4 mg weight management GI adverse events / Nausea occurred in 42% of adolescent trial participants vs
Science 349 , 989993 (2015)
If youre still eating the exact amount you started with, that number may now be too high to keep losing weight, and a slight calorie adjustment could help you get moving again
If you wish to try them, consider a time-limited trial to assess benefits
US$ 20.83
US$ 24.86
US$ 23.82
US$ 23.76
US$ 28.21
